Froelich, L., O. Peters, P. Lewczuk, O. Gruber, S. J. Teipel, H.-J. Gertz, H. Jahn, F. Jessen, A. Kurz, C. Luckhaus, M. Huell, J. Pantel, F. M. Reischies, J. Schroeder, M. Wagner, O. Rienhoff, S. Wolf, C. Bauer, J. Schuchhardt, I. Heuser, E. Ruether, F. Henn, W. Maier, J. Wiltfang and J. Kornhuber: Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. In: Alzheimer's Research and Therapy 9, 1, Seq. No.: 84 (2017).
doi: 10.1186/s13195-017-0301-7
localid: training77211
Ehrenreich, H., D. Hinze-Selch, S. Stawicki, C. Aust, S. Knolle-Veentjer, S. Wilms, G. Heinz, S. Erdag, H. Jahn, D. Degner, M. Ritzen, A. Mohr, M. Wagner, U. Schneider, M. Bohn, M. Huber, A. Czernik, T. Pollmacher, W. Maier, A.-L. Sirén, J. Klosterkötter, P. Falkai, E. Rüther, J. B. Aldenhoff and H. Krampe: Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. In: Molecular Psychiatry 12, 2, 206-220 (2007).
Krampe, H., S. Stawicki, T. Wagner, C. Bartels, C. Aust, E. Ruether, W. Poser and H. Ehrenreich: Longterm folllow-up of 180 chronic alcoholics during and after comprehensive integrated outpatient treatment: Relation of deterrent medication and outcome. In: European Psychiatry 20, Suppl. Suppl. 1, S22-S22 (2005).
Ehrenreich, H., M. Hasselblatt, C. Dembowski, L. Cepek, P. Lewczuk, M. Stiefel, H. H. Rustenbeck, N. Breiter, S. Jacob, F. Knerlich, M. Bohn, W. Poser, E. Rüther, M. Kochen, O. Gefeller, C. Gleiter, T. C. Wessel, M. De Ryck, L. Itri, H. Prange, A. Cerami, M. Brines and A. L. Sirén: Erythropoietin therapy for acute stroke is both safe and beneficial. In: Molecular Medicine 8, 8, 495-505 (2002).
The Max Planck Society does not take any responsibility for the content of this export.